BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18245064)

  • 1. Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability.
    Hans CP; Zerfaoui M; Naura AS; Catling A; Boulares AH
    Cardiovasc Res; 2008 Jun; 78(3):429-39. PubMed ID: 18245064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thieno[2,3-c]isoquinolin-5-one, a potent poly(ADP-ribose) polymerase inhibitor, promotes atherosclerotic plaque regression in high-fat diet-fed apolipoprotein E-deficient mice: effects on inflammatory markers and lipid content.
    Hans CP; Zerfaoui M; Naura AS; Troxclair D; Strong JP; Matrougui K; Boulares AH
    J Pharmacol Exp Ther; 2009 Apr; 329(1):150-8. PubMed ID: 19124646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly (ADP-Ribose) polymerase inhibition attenuates atherosclerotic plaque development in ApoE-/- mice with hyperhomocysteinemia.
    Xie JJ; Yu X; Liao YH; Chen J; Yao R; Chen Y; Liao MY; Ding YJ; Tang TT; Cheng X
    J Atheroscler Thromb; 2009 Oct; 16(5):641-53. PubMed ID: 19776495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP1 is required for adhesion molecule expression in atherogenesis.
    von Lukowicz T; Hassa PO; Lohmann C; Borén J; Braunersreuther V; Mach F; Odermatt B; Gersbach M; Camici GG; Stähli BE; Tanner FC; Hottiger MO; Lüscher TF; Matter CM
    Cardiovasc Res; 2008 Apr; 78(1):158-66. PubMed ID: 18093987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2.
    Mathews MT; Berk BC
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):711-7. PubMed ID: 18239155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite.
    Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R
    J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
    Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP-1 (Poly[ADP-Ribose] Polymerase 1) Inhibition Protects From Ang II (Angiotensin II)-Induced Abdominal Aortic Aneurysm in Mice.
    Liang ES; Bai WW; Wang H; Zhang JN; Zhang F; Ma Y; Jiang F; Yin M; Zhang MX; Chen XM; Qin WD
    Hypertension; 2018 Nov; 72(5):1189-1199. PubMed ID: 30354818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity.
    Rong JX; Blachford C; Feig JE; Bander I; Mayne J; Kusunoki J; Miller C; Davis M; Wilson M; Dehn S; Thorp E; Tabas I; Taubman MB; Rudel LL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):4-12. PubMed ID: 23139293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minocycline reduces plaque size in diet induced atherosclerosis via p27(Kip1).
    Shahzad K; Thati M; Wang H; Kashif M; Wolter J; Ranjan S; He T; Zhou Q; Blessing E; Bierhaus A; Nawroth PP; Isermann B
    Atherosclerosis; 2011 Nov; 219(1):74-83. PubMed ID: 21719015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) polymerase-2 depletion reduces doxorubicin-induced damage through SIRT1 induction.
    Szántó M; Rutkai I; Hegedus C; Czikora Á; Rózsahegyi M; Kiss B; Virág L; Gergely P; Tóth A; Bai P
    Cardiovasc Res; 2011 Dec; 92(3):430-8. PubMed ID: 21921080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability.
    Xiong Y; Yu Y; Montani JP; Yang Z; Ming XF
    J Am Heart Assoc; 2013 Jul; 2(4):e000096. PubMed ID: 23832324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase-mediated protein kinase C-delta cleavage is necessary for apoptosis of vascular smooth muscle cells.
    Kato K; Yamanouchi D; Esbona K; Kamiya K; Zhang F; Kent KC; Liu B
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2253-61. PubMed ID: 19837952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis.
    Dhingra S; Sharma AK; Arora RC; Slezak J; Singal PK
    Cardiovasc Res; 2009 Apr; 82(1):59-66. PubMed ID: 19181934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.
    Papadopoulos P; Bousette N; Al-Ramli W; You Z; Behm DJ; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Atherosclerosis; 2009 Jun; 204(2):395-404. PubMed ID: 19111831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
    Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCB-induced endothelial cell dysfunction: role of poly(ADP-ribose) polymerase.
    Helyar SG; Patel B; Headington K; El Assal M; Chatterjee PK; Pacher P; Mabley JG
    Biochem Pharmacol; 2009 Oct; 78(8):959-65. PubMed ID: 19549508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.